
Mark C Bates MD DSc (hon), FACC, FSCAI
Adult Congenital Heart Disease, Interventional Cardiology
Innovation and Healthcare Transformation Leader, CAMC Institute for Academic Medicine. CEO and Founder of Polaris
Join to View Full Profile
3200 MacCorkle AVE SECharleston, WV 25304
Phone+1 304-388-4884
Dr. Bates is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Bates is a distinguished clinician, academic, inventor, and entrepreneur. He founded one of the first multidisciplinary vascular centers in the U.S. (CAMC/WVU Vascular Center of Excellence) and has founded, led or served as Core Faculty in multiple fellowship programs across vascular medicine, surgery, and cardiology. With over 10,000 procedures performed and cases proctored in 8 countries, he has authored more than 100 peer-reviewed papers and 20 textbook chapters. His contributions have been featured at leading international conferences. He is a recipient of the AHA Heart of Gold Award and the VIVA “LIVE” Lifetime Achievement Award. In 2021, CAMC established the Mark C. Bates, MD Endowed Chair in Cardiovascular Research in his honor. He is also an elected member of the prestigious Alpha Omega Alpha Medical Honor Society. He is a prolific innovator, holds 60+ U.S. patents spanning embolic protection, gene therapy, regenerative medicine, nanotechnology, stents, drug delivery, and more. His technologies have led to multiple acquisitions and clinical translation.
Education & Training
University of Wisconsin School of Medicine & Public HealthVascular Medicine and Surgery, Cardiovascular Innovation and Intervention, 1992 - 1993
University of Kentucky College of MedicineFellowship, Cardiovascular Disease, 1989 - 1992
Charleston Area Medical Center/CAMC Institute for Academic MedicineResidency, Internal Medicine, 1986 - 1989
West Virginia University School of MedicineClass of 1986
West Virginia State University InstituteB.S., Chemistry, 1980 - 1982
Certifications & Licensure
CA State Medical License 2004 - 2026
WV State Medical License 1987 - 2026
WI State Medical License 1992 - 1993
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Presented with the Endowed Chair Dedicated in Honor (Mark C. Bates, MD Endowed Chair in Cardiovascular Medicine). CAMC Institute of Academic Medicine, 2021
- Honorary Doctorate Degree University of Charleston, 2017
- Twelfth Recipient of the LIVE AWARD - Vascular Interventional Advances (VIVA) Lifetime Achievement Award VIVA International Vascular Congress, 2016
Clinical Trials
- The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis Start of enrollment: 2007 Aug 01
- VALOR: The Talent Thoracic Stent Graft System Clinical Study Start of enrollment: 2003 Jul 01
- Controlling and Lowering Blood Pressure With The MOBIUSHD™ Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 14 citationsSex Differences in Characteristics of Patients with Infective Endocarditis: A Multicenter Study.Ruchi Bhandari, Shabnam Tiwari, Talia Alexander, Frank H Annie, Umar Kaleem
Journal of Clinical Medicine. 2022-06-18 - 30 citationsTreatment of Resistant Hypertension With Endovascular Baroreflex Amplification: 3-Year Results From the CALM-FIM Study.Monique E A M van Kleef, Chandan M Devireddy, Jan van der Heyden, Mark C Bates, George L Bakris
JACC. Cardiovascular Interventions. 2022-02-14 - 10 citationsSteep rise in drug use-associated infective endocarditis in West Virginia: Characteristics and healthcare utilization.Ruchi Bhandari, Talia Alexander, Frank H Annie, Umar Kaleem, Affan Irfan
Plos One. 2022-01-01
Journal Articles
- Long-term Comparative Outcomes of Carotid Artery Stenting Following Previous Carotid Endarterectomy vs De Novo LesionsMousa AY, AbuRahma AF, Bozzay J, Broce M, Kali M, Yacoub M, Stone P, Bates MC, J Endovasc Ther, 1/15/2015
- LB0205: CONTROLLING AND LOWERING BLOOD PRESSURE WITH THE MOBIUSHD DEVICE: FIRST-IN-MAN RESULTS (CALM-FIM STUDY)Spiering W, Van Der Heyden J, Devireddy C, Foster MT 3rd, Bates MC, Kroon AA, J Hypertens, 1/1/2015
- Initial experience with therapeutic geometric modification of the carotid bulb for true resistant hypertensionHabib N, Mahmoodi BK, Bos WJ, Tromp SC, Suttorp MJ, Bates MC, Van der Heyden J, EuroIntervention, 1/1/2015
Books/Book Chapters
Abstracts/Posters
- Endovascular Rescue of a Fused Monorail Balloon and Cerebral Embolic Protection DeviceCampbell JE, Bates MC, Elmore M, Faculty, Resident, Student Research Day, Charleston, WV, 1/17/2007
- Predictors of 10-year survival following renal artery stentingCampbell JE, Bates MC, Rashid M, Stone PA, Lavigne PS, Broce M, International Symposium on Endovascular Therapy, Miami, FL, 1/23/2006
- Predictors of 10-year survival following renal artery stentingCampbell JE, Bates MC, Rashid M, Stone PA, Lavigne PS, Broce M, Faculty, Resident, Student Research Day, Charleston, WV, 1/11/2006
Press Mentions
Challenges of Infective Endocarditis: The Opioid Crisis Hits Home & Cardiologists Can’t Go It AloneMay 10th, 2019
Another Harm from the Opioid Epidemic: More Heart InfectionsApril 26th, 2018
Nexeon Closes $4.3 Million in Private Funding Round, Has Form 10 Deemed EffectiveJanuary 23rd, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









